Welcome

Thank you for visiting our website. Laboratoria Smeets N.V. is located in Belgium in the Antwerp area. The company specializes in the blending and packaging of pharmaceutical powders. We do everything we can to be a reliable and trustworthy partner.

Pharmaceutical powders

Since it’s origin, Laboratoria Smeets has excelled in the manufacturing of powders. From blending to packaging, all processes are performeed under GMP conditions in a dedicated facility.

Blending

Obtaining homogeneous blends is paramount. Powder to powder, liquid into powder, powder in liquid, everything is feasable.
 

Packaging

We produce several hundreds of millions of powder filled sachets per year and through that experience, we have acquired a unique sachet knowhow. We also fill plastic tamper proof containers and sacs up to 25 kg. 

 

Quality

Good Manufacturing Practice (GMP) is in the genes of Laboratoria Smeets. We never compromise on quality. This is guaranteed by well trained people with long term experience within the company.

We share a passion for excellence and custormer service.
 

Total service 

For Labo Smeets, total service means flexible service. We have a range of possibilities to meet your specific needs. One of them is to simply package your products into your packaging material. These can be powders, liquids or gels.

Alternatively we offer our services for product development, purchasing, procurement, manufacturing, testing ad delivery. In other words, the full value chain design.

Confidentiality

The role of Labo Smeets is one of contract manufacturing. The products we make for you are confidential and unique for you.

 

Welcome





Labo Smeets: focus on powders

LABORATORIA SMEETS N.V.

Fotografielaan 42
B-2610 Antwerpen-Wilrijk
Tel. +32 (0)3 828 29 37
Fax +32 (0)3 830 21 36
e-mail: info@labosmeets.be

EN  NL  FR  DE  ES 

Read more...
CASE: Process Installation  

Open communication crucial in reassembly and automation of process installation for Laboratoria Smeets Large scale projects don’t always have to exceed the deadline, the budget and the stress limitations of the people involved. No, there is another way. Egemin Automation and Laboratoria Smeets proved it in their joint project to build a new production ...
Read more...
New Technology for API solubility

In collaboration with the University of Ghent, Labo Smeets has realised a new process in pharmaceutical extrusion technology, which enables us to make granules. The main application is to make pharmaceutical granule compositions to drastically improve water solubility of active ingredients. This equipment is installed and available since January 2011.

Read more...
CASE: Flexibility  

We were contacted by a company that had a large project based upon nasal therapy with essential oils. There was no supplier for the part, no clear definition of the product and no procedure lines to make the product, but there was a short deadline. Pressure in order to obtain the right information at the right timing. We agreed with the customer the precise ...
Read more...
CASE: Product innovation  

A customer identified a patented technology at one of the Belgian universities to make one of their products easier to administer. We were contacted at an early stage to help with developing the product. We jointly decided to set up a test manufacturing unit in order to produce small batches for the clinical trials. As the project outcome was uncertain, ...
Read more...
CASE: Speed to market  

A customer found an opportunity to launch an anti-allergic product in one of its markets. The opportunity came up quickly, but the product design wasn’t ready, nor were the sales forecasts. The marketing team instructed to identify the swiftest supplier to realize the product launch. In less than 2 weeks, we were able to present a fully elaborated ...
Read more...
CASE: Strategic procurement  

One of  our pharmacuetical customers is a large consumer of raw materials. Often large pharmaceutical customers are constrained with their raw materials procurement strategies. The complexity of the regulatory filing for many of their products, prevents them from obtaining the best deal. Underlying causes are the intrinsic speed of action, but also the ...
Read more...